Plasma sialic acid as a marker of the effect of the treatment on metastatic colorectal cancer (Q74201933)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470809%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

title

Plasma sialic acid as a marker of the effect of the treatment on metastatic colorectal cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470809%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

metastatic colon cancer

1 reference

1 reference

T Painbeni

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470809%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

E Gamelin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470809%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

A Cailleux

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470809%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

A Le Bouil

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470809%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

M Boisdron-Celle

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470809%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

A Daver

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470809%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

F Larra

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470809%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

P Allain

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470809%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 November 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470809%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Cancer

9 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470809%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

33

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470809%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470809%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

2216-2220

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470809%20AND%20SRC:MED&resulttype=core&format=json

Sensitivity of monoclonal antibodies to carcinoembryonic antigen, tissue polypeptide antigen, alpha-fetoprotein, carbohydrate antigen 50, and carbohydrate antigen 19-9 in the diagnosis of colorectal adenocarcinoma

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900318-3

7 January 2021

The value of CA 19-9 in gastric and colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900318-3

7 January 2021

Use and limitations of serum total and lipid-bound sialic acid concentrations as markers for colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900318-3

7 January 2021

Serum sialic acid and carcinoembryonic levels in the detection and monitoring of colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900318-3

7 January 2021

Relationship between 5-fluorouracil (5-FU) dose intensity and therapeutic response in patients with advanced colorectal cancer receiving infusional therapy containing 5-FU

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900318-3

7 January 2021

Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900318-3

7 January 2021

Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900318-3

7 January 2021

Sialic acid content in mouse myeloma cells and derived B-cell hybridomas with different metastatic potentials

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900318-3

7 January 2021

Distribution of membrane anionic sites on B16 melanoma variants with differing lung colonising potential

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900318-3

7 January 2021

Metastatic Potential Is Positively Correlated with Cell Surface Sialylation of Cultured Murine Tumor Cell Lines

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900318-3

7 January 2021

Sialic acid dependent cell adhesion to collagen IV correlates with in vivo tumorigenicity of the human colon carcinoma sublines HCT116, HCT116a and HCT116b

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900318-3

7 January 2021

Serum-sialyltransferase activity in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900318-3

7 January 2021

Total and lipid-associated serum sialic acid levels in cancer patients with different primary sites and differing degrees of metastatic involvement

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900318-3

7 January 2021

The association of preoperative serum tumour markers with Dukes' stage and survival in colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900318-3

7 January 2021

Sialic acid as a marker for differentiation between benign and malignant intracranial tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900318-3

7 January 2021

Serum concentrations of total sialic acid and sialoglycoproteins in relation to coronary heart disease risk markers

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900318-3

7 January 2021

Serum sialic acid in malignant tumors, bacterial infections, and chronic liver diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900318-3

7 January 2021

Preoperative serum levels of CEA and CA 242 in colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900318-3

7 January 2021

Comparative analysis of cancer-associated antigen CA-195, CA 19-9 and carcinoembryonic antigen in diagnosis, follow-up and monitoring of response to chemotherapy in patients with gastrointestinal cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2900318-3

7 January 2021

10.1016/S0959-8049(97)00318-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9470809%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference